VIVEbiotech will be exhibiting at booth number 564 at the Advanced Therapies Week conference to be held at the Kay Bailey Hutchison Convention Center Dallas from January 20-23.
An event organized each year by Phacilitate, the Advanced Therapies Week conference “has been the epicenter of the cell & gene therapy revolution, a dynamic and must-attend forum where breakthrough technologies and impactful partnerships come to life to transform drug development.”
Jon Alberdi, CEO, Natalia Elizalde, Chief Business Development Officer, Elliot Adams, Head of Business Development, and Aimi Arrúe, Technical Proposals Technician, will be there eager to make new connections.
Moreover, VIVEbiotech has been selected as a finalist in the CMO/CDMO of the Year Award category at the Advanced Therapies Awards. We’re honored to be among the finalists and looking forward to the awards ceremony in January.